MedPath
NMPA Approval

Ceftizoxime Sodium for Injection

国药准字H20249187

October 29, 2024

Drug Information

注射用头孢唑肟钠

注射剂

1.0g(按C₁₃H₁₃N₅O₅S₂计 )

化学药品

October 29, 2024

Company Information

Applicant Company

广州市黄埔区神舟路288号D栋312房

Manufacturing Company

福建省福州市福清市江阴工业集中区高港大道6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.